ALDH1A1 can be useful as a CSC therapy target in cancer tissues that normally express a low level of ALDH1A1, such as breast, lung, colon and gastric epithelium cancer, but not in tissues that normally have high ALDH1A1 expression, such as the liver and pancreatic cancer. The gene discussed is ALDH1A1; the disease is pancreatic neoplasm.